Sensor for detecting biomarkers in a fluid sample and methods of use
AssigneesArizona Board of Regents on behalf of Arizona State University, American University of Beirut
InventorsJitendran Muthuswamy, Massoud Khraiche
Life of this patent
Estimating the term…
Abstract
The invention relates to a diagnostic platform for detection of biomarkers associated with a particular condition, disease, or disorder and methods of making and using the same. In various embodiments, the diagnostic platform includes a sensing device and an electronic reading platform. Aspects of the invention are directed to a diagnostic platform for detection of at least one biomarker in a fluid sample. In embodiments, the diagnostic platform comprises a sensing device configured to receive the fluid sample. The platform can further comprise an electronic reading platform and a computing device. The electronic reading platform can be configured to activate the sensor.
Claims30
A diagnostic platform for detection of at least one biomarker in a fluid sample comprising:
- a quantitative sensing device configured to receive the fluid sample, wherein the fluid sample comprises blood, blood serum, or plasma;
- an electronic reading platform;
- and
- a computing device;
- wherein the sensing device comprises
- a layer of piezoelectric material comprising two faces;
- at least one electrode layer, wherein the at least one electrode layer is affixed to one face of the piezoelectric material, wherein the at least one electrode layer comprises
- a thickness of about 33 nm to about 300 nm, and
- a diameter of about 150 μm to about 350 μm;
- a second reference electrode layer that is affixed to a second face of the piezoelectric material;
- at least two disposable sensor cartridges, wherein one of the at least two sensor cartridges comprises a means for detecting IgG antibodies in the fluid sample and the other sensor cartridge comprises a means for detecting IgM antibodies in the fluid sample, wherein the IgG and IgM antibodies are quantitively detected;
- a Q-factor of at least 10,000;
- an operating frequency of about 10 MHz to about 90 MHz;
- and
- a sensing layer disposed upon the at least one electrode layer, wherein the sensing layer is configured to bind the at least one biomarker for a disease or condition, wherein the biomarker comprises an IgG antibody, an IgM antibody, or a combination thereof;
- wherein the quantitative sensing device is communicatively linked with the electronic reading platform,
- wherein the electronic reading platform is configured to receive sensor data from the sensing device and to communicate the data to the computing device,
- and wherein the computing device is configured to determine the presence, absence, or amount of the at least one biomarker;
- and
- wherein the diagnostic platform quantitatively detects the at least one biomarker within about 10 minutes.
Dependencies are inferred from the claim text.